Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 14 September 1990:
Vol. 249. no. 4974, pp. 1288 - 1290
DOI: 10.1126/science.1697983
Prev | Table of Contents | Next

Articles

Science, Vol 249, Issue 4974, 1288-1290
Copyright © 1990 by American Association for the Advancement of Science

articles

5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes

WM Rideout 3rd, GA Coetzee, AF Olumi, and PA Jones

Urological Cancer Research Laboratory, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles 90033.

Direct genomic sequencing revealed that cytosine residues known to have undergone a germ-line mutation in the low density lipoprotein receptor gene or somatic mutations in the p53 tumor suppressor gene were methylated in all normal human tissues analyzed. Thus, these mutations should be scored as transitions from 5-methylcytosine to thymine rather than from cytosine to thymine. Methylated cytosines occur exclusively at CpG dinucleotides, which, although markedly underrepresented in human DNA, are sites for more than 30 percent of all known disease-related point mutations. Thus, 5-methylcytosine functions as an endogenous mutagen and carcinogen in humans, in that methylation seems to increase the potential for mutation at cytosine residues at least by a factor of 10.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Kinetics of deamination and Cu(II)/H2O2/Ascorbate-induced formation of 5-methylcytosine glycol at CpG sites in duplex DNA.
H. Cao, Y. Jiang, and Y. Wang (2009)
Nucleic Acids Res. 37, 6635-6643
   Abstract »    Full Text »    PDF »
High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing.
E. Hodges, A. D. Smith, J. Kendall, Z. Xuan, K. Ravi, M. Rooks, M. Q. Zhang, K. Ye, A. Bhattacharjee, L. Brizuela, et al. (2009)
Genome Res. 19, 1593-1605
   Abstract »    Full Text »    PDF »
Cancer Prevention: From 1727 to Milestones of the Past 100 Years.
S. M. Lippman and E. T. Hawk (2009)
Cancer Res. 69, 5269-5284
   Abstract »    Full Text »    PDF »
Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes.
S. Martinelli, P. Torreri, M. Tinti, L. Stella, G. Bocchinfuso, E. Flex, A. Grottesi, M. Ceccarini, A. Palleschi, G. Cesareni, et al. (2008)
Hum. Mol. Genet. 17, 2018-2029
   Abstract »    Full Text »    PDF »
Excision of 5-Halogenated Uracils by Human Thymine DNA Glycosylase: ROBUST ACTIVITY FOR DNA CONTEXTS OTHER THAN CpG.
M. T. Morgan, M. T. Bennett, and A. C. Drohat (2007)
J. Biol. Chem. 282, 27578-27586
   Abstract »    Full Text »    PDF »
Quantification of oxidative single-base and intrastrand cross-link lesions in unmethylated and CpG-methylated DNA induced by Fenton-type reagents.
H. Cao and Y. Wang (2007)
Nucleic Acids Res.
   Abstract »    Full Text »    PDF »
Mutator pathways unleashed by epigenetic silencing in human cancer.
F. V. Jacinto and M. Esteller (2007)
Mutagenesis 22, 247-253
   Abstract »    Full Text »    PDF »
Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification.
A. P. Mitra, R. H. Datar, and R. J. Cote (2006)
J. Clin. Oncol. 24, 5552-5564
   Abstract »    Full Text »    PDF »
Analysis of Genetic Alterations and Clonal Proliferation in Children Treated for Acute Lymphocytic Leukemia..
H. E. Kendall, P. M. Vacek, J. L. Rivers, S. C. Rice, T. L. Messier, and B. A. Finette (2006)
Cancer Res. 66, 8455-8461
   Abstract »    Full Text »    PDF »
Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis.
A. Besaratinia and G. P. Pfeifer (2006)
Carcinogenesis 27, 1526-1537
   Abstract »    Full Text »    PDF »
De novo CpG Island Methylation in Human Cancer Cells.
K.-W. Jair, K. E. Bachman, H. Suzuki, A. H. Ting, I. Rhee, R.-W. C. Yen, S. B. Baylin, and K. E. Schuebel (2006)
Cancer Res. 66, 682-692
   Abstract »    Full Text »    PDF »
Epigenetics and its Implications for Plant Biology 2. The 'Epigenetic Epiphany': Epigenetics, Evolution and Beyond.
R. T. GRANT-DOWNTON and H. G. DICKINSON (2006)
Ann. Bot. 97, 11-27
   Abstract »    Full Text »    PDF »
PCR-Induced Sequence Alterations Hamper the Typing of Prehistoric Bone Samples for Diagnostic Achondroplasia Mutations.
C. M. Pusch, M. Broghammer, G. J. Nicholson, A. G. Nerlich, A. Zink, I. Kennerknecht, L. Bachmann, and N. Blin (2004)
Mol. Biol. Evol. 21, 2005-2011
   Abstract »    Full Text »    PDF »
Modeling the Impact of DNA Methylation on the Evolution of BRCA1 in Mammals.
G. A. Huttley (2004)
Mol. Biol. Evol. 21, 1760-1768
   Abstract »    Full Text »    PDF »
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements.
A. S. Yang, M. R. H. Estecio, K. Doshi, Y. Kondo, E. H. Tajara, and J.-P. J. Issa (2004)
Nucleic Acids Res. 32, e38
   Abstract »    Full Text »    PDF »
Gene Silencing in Cancer in Association with Promoter Hypermethylation.
J. G. Herman and S. B. Baylin (2003)
N. Engl. J. Med. 349, 2042-2054
   Full Text »    PDF »
UVA induces C->T transitions at methyl-CpG-associated dipyrimidine sites in mouse skin epidermis more frequently than UVB.
H. Ikehata, H. Kudo, T. Masuda, and T. Ono (2003)
Mutagenesis 18, 511-519
   Abstract »    Full Text »    PDF »
Association between Low Dietary Folate Intake and Suboptimal Cellular DNA Repair Capacity.
Q. Wei, H. Shen, L.-E Wang, C. M. Duphorne, P. C. Pillow, Z. Guo, Y. Qiao, and M. R. Spitz (2003)
Cancer Epidemiol. Biomarkers Prev. 12, 963-969
   Abstract »    Full Text »    PDF »
Deamination of 5-Methylcytosines within Cyclobutane Pyrimidine Dimers Is an Important Component of UVB Mutagenesis.
D.-H. Lee and G. P. Pfeifer (2003)
J. Biol. Chem. 278, 10314-10321
   Abstract »    Full Text »    PDF »
Mutational Signature of the Proximate Bladder Carcinogen N-Hydroxy-4-acetylaminobiphenyl: Inconsistency with the p53 Mutational Spectrum in Bladder Cancer.
A. Besaratinia, S. E. Bates, and G. P. Pfeifer (2002)
Cancer Res. 62, 4331-4338
   Abstract »    Full Text »    PDF »
Smoking, lung cancers and their TP53 mutations.
C. S. Cooper (2002)
Mutagenesis 17, 279-280
   Full Text »    PDF »
Increased Frequency of p53 Mutation in Sporadic Colorectal Cancer from Cigarette Smokers.
M. Miyaki, T. Iijima, R. Ishii, Y. Kita, M. Koike, T. Kuroki, and T. Mori (2002)
Jpn. J. Clin. Oncol. 32, 196-201
   Abstract »    Full Text »    PDF »
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.
A. Shibata, J. Parsonnet, T. A. Longacre, M. I. Garcia, B. Puligandla, R.E. Davis, J. H. Vogelman, N. Orentreich, and L. A. Habel (2002)
Carcinogenesis 23, 419-424
   Abstract »    Full Text »    PDF »
Epidemiology and Molecular Pathology of Gallbladder Cancer.
E. C. Lazcano-Ponce, J. F. Miquel, N. Munoz, R. Herrero, C. Ferrecio, I. I. Wistuba, P. Alonso de Ruiz, G. Aristi Urista, and F. Nervi (2001)
CA Cancer J Clin 51, 349-364
   Abstract »    Full Text »    PDF »
O6-Methylguanine-DNA Methyltransferase Promoter Hypermethylation Shifts the p53 Mutational Spectrum in Non-Small Cell Lung Cancer.
P. Wolf, Y. C. Hu, K. Doffek, D. Sidransky, and S. A. Ahrendt (2001)
Cancer Res. 61, 8113-8117
   Abstract »    Full Text »    PDF »
Protection by Dietary Compounds against Mutation in a Transgenic Rodent.
J. G. de Boer (2001)
J. Nutr. 131, 3082S-3086
   Abstract »    Full Text »    PDF »
An Inherited Mutation Outside the Highly Conserved DNA-Binding Domain of the p53 Tumor Suppressor Protein in Children and Adults with Sporadic Adrenocortical Tumors.
A. C. Latronico, E. M. Pinto, S. Domenice, M. C. B. V. Fragoso, R. M. Martin, M. C. Zerbini, A. M. Lucon, and B. B. Mendonca (2001)
J. Clin. Endocrinol. Metab. 86, 4970-4973
   Abstract »    Full Text »    PDF »
Methylated CpG Dinucleotides Are the Preferential Targets for G-to-T Transversion Mutations Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells: Similarities with the p53 Mutation Spectrum in Smoking-associated Lung Cancers.
J.-H. Yoon, L. E. Smith, Z. Feng, M.-s. Tang, C.-S. Lee, and G. P. Pfeifer (2001)
Cancer Res. 61, 7110-7117
   Abstract »    Full Text »    PDF »
The Role of DNA Methylation in Mammalian Epigenetics.
P. A. Jones and D. Takai (2001)
Science 293, 1068-1070
   Abstract »    Full Text »    PDF »
Synthesis and properties of oligonucleotides containing 5-formyl-2'-deoxycytidine: in vitro DNA polymerase reactions on DNA templates containing 5-formyl-2'-deoxycytidine.
N. Karino, Y. Ueno, and A. Matsuda (2001)
Nucleic Acids Res. 29, 2456-2463
   Abstract »    Full Text »    PDF »
Promoter Hypermethylation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase Is Associated with the Presence of G:C to A:T Transition Mutations in p53 in Human Colorectal Tumorigenesis.
M. Esteller, R.-A. Risques, M. Toyota, G. Capella, V. Moreno, M. A. Peinado, S. B. Baylin, and J. G. Herman (2001)
Cancer Res. 61, 4689-4692
   Abstract »    Full Text »    PDF »
Missense mutation of the interleukin-12 receptor {beta}1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection.
T. Sakai, M. Matsuoka, M. Aoki, K. Nosaka, and H. Mitsuya (2001)
Blood 97, 2688-2694
   Abstract »    Full Text »    PDF »
The p53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer.
R. E. Buller, T. A. Lallas, M. S. Shahin, A. K. Sood, M. Hatterman-Zogg, B. Anderson, J. I. Sorosky, and P. A. Kirby (2001)
Clin. Cancer Res. 7, 831-838
   Abstract »    Full Text »
Identification of single nucleotide polymorphisms in human DNA repair genes.
B. N. Ford, C. C. Ruttan, V. L. Kyle, M. E. Brackley, and B. W. Glickman (2000)
Carcinogenesis 21, 1977-1981
   Abstract »    Full Text »    PDF »
Cladistic Structure Within the Human Lipoprotein Lipase Gene and Its Implications for Phenotypic Association Studies.
A. R. Templeton, K. M. Weiss, D. A. Nickerson, E. Boerwinkle, and C. F. Sing (2000)
Genetics 156, 1259-1275
   Abstract »    Full Text »
The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location.
M Rugge, Y-H Shiao, G Busatto, M Cassaro, C Strobbe, V M Russo, G Leo, A R Parenti, A Scapinello, P Arslan, et al. (2000)
Mol. Pathol. 53, 207-210
   Abstract »    Full Text »
Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons.
L. E. Smith, M. F. Denissenko, W. P. Bennett, H. Li, S. Amin, M.-s. Tang, and G. P. Pfeifer (2000)
J Natl Cancer Inst 92, 803-811
   Abstract »    Full Text »    PDF »
DNA methylation: past, present and future directions.
K. D. Robertson and P. A.Jones (2000)
Carcinogenesis 21, 461-467
   Abstract »    Full Text »    PDF »
The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer.
K.-J. Sohn, M. Puchyr, R. N. salomon, F. Graeme-Cook, L. Fung, S.-W. Choi, J. B. mason, A. Medline, and Y.-I. Kim (1999)
Carcinogenesis 20, 2345-2350
   Abstract »    Full Text »    PDF »
Risk Factors for Ki-ras Protooncogene Mutation in Sporadic Colorectal Adenomas.
M. E. Martinez, T. Maltzman, J. R. Marshall, J. Einspahr, M. E. Reid, R. Sampliner, D. J. Ahnen, S. R. Hamilton, and D. S. Alberts (1999)
Cancer Res. 59, 5181-5185
   Abstract »    Full Text »    PDF »
Growth Phase-Dependent Regulation of Vsr Endonuclease May Contribute to 5-Methylcytosine Mutational Hot Spots in Escherichia coli.
G. Macintyre, P. Pitsikas, and C. G. Cupples (1999)
J. Bacteriol. 181, 4435-4436
   Abstract »    Full Text »
Tamoxifen induces G:C->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
R. Davies, T. W. Gant, L. L. Smith, and J. A. Styles (1999)
Carcinogenesis 20, 1351-1356
   Abstract »    Full Text »    PDF »
Comparison of Mutations in the p53 and K-ras Genes in Lung Carcinomas from Smoking and Nonsmoking Women1.
R. Gealy, L. Zhang, J. M. Siegfried, J. D. Luketich, and P. Keohavong (1999)
Cancer Epidemiol. Biomarkers Prev. 8, 297-302
   Abstract »    Full Text »    PDF »
Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells.
S. N. Rodin and A. S. Rodin (1998)
PNAS 95, 11927-11932
   Abstract »    Full Text »    PDF »
Infection with Human Immunodeficiency Virus Type 1 Upregulates DNA Methyltransferase, Resulting in De Novo Methylation of the Gamma Interferon (IFN-gamma ) Promoter and Subsequent Downregulation of IFN-gamma Production.
J. A. Mikovits, H. A. Young, P. Vertino, J.-P. J. Issa, P. M. Pitha, S. Turcoski-Corrales, D. D. Taub, C. L. Petrow, S. B. Baylin, and F. W. Ruscetti (1998)
Mol. Cell. Biol. 18, 5166-5177
   Abstract »    Full Text »
Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters.
H.-P. Holzapfel, D. Fuhrer, P. Wonerow, G. Weinland, W. A. Scherbaum, and R. Paschke (1997)
J. Clin. Endocrinol. Metab. 82, 4229-4233
   Abstract »    Full Text »    PDF »
Cytosine methylation determines hot spots of DNA damage in the human P53 gene.
M. F. Denissenko, J. X. Chen, M.-s. Tang, and G. P. Pfeifer (1997)
PNAS 94, 3893-3898
   Abstract »    Full Text »    PDF »
Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.
S. Ramchandani, A. R. MacLeod, M. Pinard, E. von Hofe, and M. Szyf (1997)
PNAS 94, 684-689
   Abstract »    Full Text »    PDF »
MUTATIONS OF p53 IN BARRETT'S ESOPHAGUS AND BARRETT'S CANCER: A PROSPECTIVE STUDY OF NINETY-EIGHT CASES.
P. M. Schneider, A. G. Casson, B. Levin, H. S. Garewal, A. H. Hoelscher, K. Becker, H.-J. Dittler, K. R. Cleary, M. Troster, J. Ruediger Siewert, et al. (1996)
J. Thorac. Cardiovasc. Surg. 111, 323-333
   Abstract »    Full Text »
p53: at the crossroads of molecular carcinogenesis and risk assessment.
C. Harris (1993)
Science 262, 1980-1981
   PDF »
Platform Presentations.
(1993)
Toxicol Pathol 21, 611-623
   PDF »
Analysis of chromatin structure by ligation-mediated PCR..
G P Pfeifer (1992)
Genome Res. 2, 107-111
   PDF »
DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.
D. Wink, K. Kasprzak, C. Maragos, R. Elespuru, M Misra, T. Dunams, T. Cebula, W. Koch, A. Andrews, J. Allen, et al. (1991)
Science 254, 1001-1003
   Abstract »    PDF »
The ligase chain reaction in a PCR world..
F Barany (1991)
Genome Res. 1, 5-16
   PDF »
p53 mutations in human cancers.
M Hollstein, D Sidransky, B Vogelstein, and C. Harris (1991)
Science 253, 49-53
   Abstract »    PDF »
Human lung cancer and p53: The interplay between mutagenesis and selection.
S. N. Rodin and A. S. Rodin (2000)
PNAS 97, 12244-12249
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)